• Aluminium pouches with a Microwell Plate coated with monoclonal antibody to rat IFN-γ (8X12)
• 2 vials human IFN-γ Standard lyophilized, 20000 pg/ml upon reconstitution
• 2 vials concentrated Biotin-Conjugate anti-human IFN-γ antibody
• 2 vials Streptavidin-HRP solution,
• 1 bottle Standard /sample Diluent
• 1 bottle Biotin-Conjugate antibody Diluent
• 1 bottle Streptavidin-HRP Diluent
• 1 bottle Wash Buffer Concentrate 20x (PBS with 1% Tween-20)
• 1 vial Substrate Solution
• 1 vial Stop Solution
• 3 pieces Adhesive Films
• package insert

Interferon gamma (IFN-γ) is a multifunctional protein first observed as an antiviral activity in cultures of Sindbis virus-infected human leukocytes stimulated by PHA (1). Produced by Tlymphocytes and natural killer (NK) cells, IFN-γ ?is now known to be both an inhibitor of viral replication and a regulator of numerous immunological functions. Human IFN-γ?is reported to be active only on human and non-human primate cells (5). The biochemistry and biological activities of the interferons have been extensively reviewed (2-9).

Rat IFN-γ cDNA encodes a 156 amino acid (aa) residue precursor protein with a putative 19 aa residue signal peptide that is cleaved to generate the mature protein which contains two potential N-glycosylation sites (10-12). Rat IFN-γ shares approximately 87% and 39% amino acid sequence identity with mouse IFN-γ and human IFN-γ , respectively. Consistent with their degrees of shared homology, rat A receptor for IFN-γ?has been identified and its gene localized to chromosome 6 (13,14). Apparently the product of a single gene, the receptor is a single chain 90 kDa glycoprotein that shows a high degree of species-specific binding of IFN-γ?(15-18).

Functionally, IFN-γ ?produces a variety of effects. Produced by CD8+, NK, gd,and TH1 T helper cells, IFN-γ ?has documented antiviral, antiprotozoal and immunomodulatory effects on cell proliferation and apoptosis, as well as the stimulation and repression of a variety of genes (19-22) he antiprotozoal activity of IFN-γ ?against Toxoplasma and Chlamydia is believed to result from indoleamine 2,3-dioxygenase activity, an enzyme induced by IFN-γ ?(23).The immunomodulatory effects of IFN-γ? are extensive and diverse. In monocyte/macrophages, the activities of IFN-γ?include: increasing the expression of class I and II MHC antigens; increasing the production of IL-1, platelet-activating factor, H2O2, and pterin; protection of monocytes against LAK cell-mediated lysis; downregulation of IL-8 mRNA expression that is upregulated by IL-2; and, with lipopolysaccharide, induction of NO production.Finally, IFN-γ?has been shown to upregulate ICAM-1, but not E-Selectin or VCAM-1, expression on endothelial cells.

Wheelock, E.F. (1965) Science 149:310.

Ijzermans, J.M. and R.L. Marquet (1989) Immunobiol. 179:456.

Mogensen, S.C. and J.L. Virelizier (1987) Interferon 8:55.

Grossberg, S.E. et al. (1989) Experientia 45:508.

Adolf, G.R. (1985) Oncology (Suppl. 1) 42:33.

Samuel, C.E. (1991) Virology 183:1.

Pellegrini, S. and C. Schindler (1993) Trends Biochem. Sci. 18:338.

Reiter, Z. (1993) J. Interferon Res. 13:247.

Boehm, U. et al. (1997) Annu. Rev. Immunol. 15:749.

Puddu, P. et al. (1997) J. Immunol. 159:3490.

Yoshimoto, T. et al. (1997) Proc. Natl. Acad. Sci. USA 94:3948.

Dijkema, R. et al. (1986) Meth. Enzymol. 119:453.

Rashidbaigi, A. et al. (1986) Proc. Natl. Acad. Sci. USA 83:384.

Pfizenmaier, K. et al. (1988) J. Immunol. 141:856.

Aguet, M. et al. (1988) Cell 55:273.

Fischer, D.G. et al. (1988) J. Biol. Chem. 263:2632.

Calderon, J. et al. (1988) Proc. Natl. Acad. Sci. USA 85:4837.

Paliard, X. et al. (1988) J. Immunol. 141:849.

Christmas, S.E. (1992) Chem. Immunol. 53:32.

Locksley, R.M. and P. Scott (1991) Immunoparasitology Today A58-A61.

Billiau, A. and R. Dijkmans (1990) Biochem. Pharmacol. 40:1433.

Sen, G.C. and P. Lengyel (1992) J. Biol. Chem. 267:5017.

Gusella, G.L. et al. (1993) J. Immunol. 151:2725.